Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sanofi-Regeneron’s Dupixent gets FDA’s nod for skin condition
FDA clears Dupixent for chronic spontaneous urticaria in patients aged 12 and above, expanding its use in immune-related skin…
Innovent’s Sycume to transform thyroid eye disease treatment landscape in China and Asia: GlobalData
Sycume becomes China’s first approved IGF-1R monoclonal antibody for thyroid eye disease, offering a new treatment option after…
AI does not just make clinical trials faster; it makes them smarter
Santhosh A F, VP, Asia Pacific South & India, Medidata highlights how AI is improving the efficiency and speed of the clinical…
A troubling new development in India’s QR code saga
Dr Avi Chaudhuri, a global expert on anti-counterfeiting has written extensively on the deficits of the recently mandated QR…
US FDA issues EIR for Lupin’s injectable facility in Nagpur
Lupin receives Establishment Inspection Report for injectable unit following US FDA inspection in June 2024
Venus Remedies’ VRP-034 receives QIDP designation from US FDA
The QIDP designation provides regulatory benefits, advancing efforts to combat antimicrobial resistance
India restricts use of Chlorpheniramine Maleate and Phenylephrine Hydrochloride FDC in children…
Manufacturers required to display warning on labels, inserts and promotional material following safety concerns
Glenmark to launch generic version of Adderall Tablets in the US market by May 2025
Company announces bioequivalent and therapeutically equivalent version of Mixed Salts of a Single Entity Amphetamine Product…
Pharma experts spotlight GenAI’s transformative role in life sciences
Leaders from GSK, L’Oréal Lifesciences, Sravathi AI, and GAVS discussed how generative AI is being applied for drug discovery,…
Shilpa Medicare receives CDSCO SEC Nod for IND Nor UDCA tablets for NAFLD treatment
Shilpa Medicare secures Subject Expert Committee approval for its novel therapy Nor Ursodeoxycholic Acid, following positive phase…